A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
While there is no doubt that benzodiazepine administration leads to transient cognitive impairment in healthy adults, the nature and magnitude of such impairment has not been well described. The cognitive effects of a single dose of alprazolam 0.5 and 1 mg were therefore assessed in 36 healthy adults on measures of psychomotor function, visual attention, working memory, planning and learning in a double‐blind parallel‐groups study. Measures of these different cognitive functions were selected on the basis of their brevity and because they yielded distributions of performance data that were without skew, floor or ceiling effects of range restriction (i.e. normal distributions). With data satisfying the assumptions for parametric analysis, measures of effect size could be computed in addition to significance testing, thus allowing for direct and meaningful comparison between the different performance measures used. Alprazolam 0.5 mg reduced only the speed of attentional performance although the magnitude of this reduction was large (d = 0.8). At 1.0 mg, impairments in psychomotor function, equivalent to that seen for attentional function at the lower dose, were observed. In addition, moderate (d approx = 0.5) impairments in working memory, and learning also became obvious. When considered together, these results suggest that low‐dose alprazolam primarily alters visual attentional function. At the higher dose psychomotor functions also become impaired, and it is likely that the combination of these led to the observed moderate impairments in higher level executive and memory processes. The current study also illustrates a method for directly comparing the magnitude of change in cognitive function between measures with different performance metrics. Copyright © 2005 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis of experiments with matched groups or repeated measures designs
Dunlap, W. P., Cortina, J. M., Vaslow, J. B., & Burke, M. J. (1996) · Psychological Methods · doi:10.1037/1082-989x.1.2.170 · Cited by 1,693 · cited 3×
“Zakzanis, 2001) or within-groups over time (e.g. Dunlap’s d; Dunlap et al., 1996), it has not been applied routinely in investigations of the effects of medication, despite the general agreement that information about effect size is as important as information about statistical significance.”
BackgroundMethodZakzanis, K. K. (2001) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/16.7.653 · Cited by 346 · cited 1×
“Whereas this approach is used commonly for the meta-analysis of differences between groups (e.g. Zakzanis, 2001) or within-groups over time (e.g. Dunlap’s d; Dunlap et al., 1996), it has not been applied routinely in investigations of the effects of medication, despite the general agreement that…”
Method
Cited by
PIETRZAK, R., MOLLICA, C., MARUFF, P., & SNYDER, P. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.10.002 · Cited by 214
Self-citationShiroma, P. R., Albott, C. S., Johns, B., Thuras, P., Wels, J., & Lim, K. O. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714001011 · Cited by 126
Trait impulsiveness and executive function in healthy young adults
Pietrzak, R. H., Sprague, A., & Snyder, P. J. (2008) · Journal of Research in Personality · doi:10.1016/j.jrp.2008.03.004 · Cited by 45
Self-citationDaglas, R., Cotton, S. M., Allott, K., Yücel, M., Macneil, C. A., Hasty, M. K., Murphy, B., Pantelis, C., Hallam, K. T., Henry, L. P., et al. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2015.09.460 · Cited by 31
Metadata
- Authors
- Snyder, P. J., Werth, J., Giordani, B., Caveney, A. F., Feltner, D., & Maruff, P.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 2005-05-23
- Volume
- 20
- Issue
- 4
- Pages
- 263-273
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W2094324240
- Cited by
- 108
- References
- 2
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam. https://app.cochat.ai/papers/10.1002/hup.692
- The paper
- Snyder, P. J., Werth, J., Giordani, B., Caveney, A. F., Feltner, D., & Maruff, P. (2005). A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.692
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.